Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix

Area of Science:

• Cell Biology
• Biochemistry
• Extracellular Matrix Research

Background:

• The urokinase-type plasminogen activator receptor (uPA-R) modulates cell adhesion and proteolytic activity.
• uPA binding influences uPA-R affinity for vitronectin (VTN) and can lead to receptor cleavage.
• Previous studies indicated uPA-R's role in normal thyroid cell adhesion to VTN.

Purpose of the Study:

• To investigate the effect of urokinase-type plasminogen activator (uPA) on normal thyroid cell adhesion to extracellular matrix (ECM) components.
• To elucidate the mechanisms underlying uPA-mediated changes in cell adhesion.

Main Methods:

• Treatment of normal thyroid cells with uPA for varying durations.
• Assessment of cell adhesion to fibronectin, collagen, laminin, and vitronectin.
• Analysis of uPA-R cleavage and cell-surface expression of integrins alpha(v) and beta3.

Main Results:

• Short-term uPA treatment did not alter thyroid cell adhesion to ECM components.
• Prolonged uPA treatment significantly increased cell adhesion to VTN and moderately to other ECMs.
• Increased cell adhesion correlated with elevated cell-surface expression of integrin beta3 and alpha(v), not uPA-R cleavage.

Conclusions:

• Prolonged uPA exposure enhances normal thyroid cell adhesion to ECM components, particularly VTN.
• This enhanced adhesion is primarily mediated by the upregulation of integrin alpha(v)beta3.
• uPA-R cleavage is not the mechanism responsible for the observed increase in cell adhesivity.